Felicia L. Svedlund

Felicia L. Svedlund, Ph.D.

Senior Consultant

Dr. Felicia L. Svedlund is a Senior Consultant at ESi.  Dr. Svedlund has over 13 years of broad experience in the realms of materials science and engineering, biomaterials, and biomedical engineering and possesses a comprehensive understanding of the complexities involved in the development and application of medical devices.  Dr. Svedlund’s expertise encompasses the design, testing, and manufacture of medical devices and the materials from which they are constructed; failure analysis and non-destructive examination of medical devices and the multi-factorial assessment of their performance; and evaluation of medical device design, testing, manufacturing, risk management, postmarket surveillance, and regulatory documentation to ensure compliance with Quality System Regulation (QSR), U.S. Food and Drug Administration’s (FDA) requirements and guidance documents, and consensus standards, such as American Society for Testing and Materials (ASTM) and International Organization of Standardization (ISO).

Dr. Svedlund's unique approach to failure analysis and evaluation of explanted medical devices sets her apart in the industry.  She incorporates a multi-factorial approach, considering device factors, as well as patient and surgical factors.  Her expertise extends to various categories of medical devices and surgical instruments, including orthopaedic devices like total knee arthroplasty, total hip arthroplasty, fracture fixation devices, and spinal implant devices, as well as interventional cardiology devices, surgical coagulation and cutting devices, women’s health and feminine hygiene products, inferior vena cava (IVC) filters, ventilators, and wearable cardiac defibrillators.


  • Failure Analysis of Medical Devices, Journal of Failure Analysis and Prevention, February 2022
  • Failure Analysis of Medical Devices.” (Book Chapter), ASM Handbook - Analysis and Prevention of Component and Equipment Failures, January 2021
  • Heterogeneity of randomized controlled trials of fecal microbiota transplantation in recurrent Clostridioides difficile infection, Digestive Diseases and Sciences, January 2021
  • A Picture Is Worth a Thousand Words—Using Imaging to Support Your Case, DRI Rx for the Defense, Volume 28, Issue 1, March 2020
  • Multivalent conjugates of basic fibroblast growth factor enhance in vitro proliferation and migration of endothelial cells, Biomaterials Science, January 2018
  • Branching Analysis of Multivalent Conjugates Using Size Exclusion Chromatography-Multiangle Light Scattering, Biomacromolecules, 17(10):3162-3171, January 2016
  • Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro, Biomaterials, Jul 31; 93:95-105, July 2016
  • See CV for further publications

Home Office

California - Irvine

15235 Alton Parkway Suite 120 Irvine, CA 92618
  • Phone: (949) 336-9001
  • Fax: (949) 336-9020

ESi's expertise spans dozens of industries and specializations organized across several practice groups, each staffed by dozens of in-house experts with the technical knowledge, hands-on expertise, and courtroom experience required to execute projects for and with our clients from start to finish.

Contact Us